ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Re-Aim Therapeutics Ltd

Re-Aim Therapeutics Ltd is an active company incorporated on 29 April 2024 with the registered office located in Oxford, Oxfordshire. Re-Aim Therapeutics Ltd was registered 1 year 9 months ago.
Status
Active
Active since incorporation
Company No
15689618
Private limited company
Age
1 year 9 months
Incorporated 29 April 2024
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 28 April 2025 (9 months ago)
Next confirmation dated 28 April 2026
Due by 12 May 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 29 Apr30 Apr 2025 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2026
Due by 31 December 2026 (10 months remaining)
Contact
Address
Innovation Building Old Campus Road
Roosevelt Drive
Oxford
OX3 7FZ
England
Address changed on 9 Jul 2025 (7 months ago)
Previous address was 35 Ballards Lane London N3 1XW United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
5
Shareholders
10
Controllers (PSC)
2
Director • PSC • British • Lives in UK • Born in Sep 1976
Director • American • Lives in Switzerland • Born in Sep 1967
Director • Dutch • Lives in Netherlands • Born in Mar 1976
Director • Commercial Director • French • Lives in England • Born in Dec 1993
Director • British • Lives in England • Born in Nov 1975
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Kesmalea Therapeutics Limited
Justian Craig Fox is a mutual person.
Active
Isogenix Limited
Justian Craig Fox is a mutual person.
Active
Matchbio Limited
Justian Craig Fox is a mutual person.
Active
Kodiform Therapeutics Limited
Justian Craig Fox is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2025–2025)
Period Ended
30 Apr 2025
For period 30 Apr30 Apr 2025
Traded for 12 months
Cash in Bank
£28.29K
Turnover
Unreported
Employees
1
Total Assets
£64.6K
Total Liabilities
-£78.66K
Net Assets
-£14.06K
Debt Ratio (%)
122%
Latest Activity
Full Accounts Submitted
18 Days Ago on 26 Jan 2026
Accounting Period Shortened
4 Months Ago on 9 Oct 2025
Syncona Portfolio Limited (PSC) Appointed
4 Months Ago on 3 Oct 2025
Dr Asher Maroof (PSC) Details Changed
4 Months Ago on 3 Oct 2025
Mr Roel Bulthuis Appointed
4 Months Ago on 2 Oct 2025
Mr Pierre-Louis Emmanuel Joffrin Appointed
4 Months Ago on 2 Oct 2025
Mr John Tsai Appointed
4 Months Ago on 2 Oct 2025
Mr Justian Craig Fox Appointed
4 Months Ago on 2 Oct 2025
Jason Goldstein Resigned
4 Months Ago on 2 Oct 2025
Registered Address Changed
7 Months Ago on 9 Jul 2025
Get Credit Report
Discover Re-Aim Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 30 April 2025
Submitted on 26 Jan 2026
Notification of Syncona Portfolio Limited as a person with significant control on 3 October 2025
Submitted on 4 Nov 2025
Change of details for Dr Asher Maroof as a person with significant control on 3 October 2025
Submitted on 4 Nov 2025
Memorandum and Articles of Association
Submitted on 10 Oct 2025
Memorandum and Articles of Association
Submitted on 10 Oct 2025
Resolutions
Submitted on 10 Oct 2025
Current accounting period shortened from 30 April 2026 to 31 March 2026
Submitted on 9 Oct 2025
Statement of capital following an allotment of shares on 3 October 2025
Submitted on 7 Oct 2025
Appointment of Mr Roel Bulthuis as a director on 2 October 2025
Submitted on 7 Oct 2025
Appointment of Mr Pierre-Louis Emmanuel Joffrin as a director on 2 October 2025
Submitted on 7 Oct 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year